During the past decade, Body Positive conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Body Positive" are "HIV Infections" (3 trials). Many other conditions were trialed in "Body Positive" in a lesser frequency.

Most popular intervention types in "Body Positive" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (2 trials), "Nelfinavir mesylate" (2 trials), "Stavudine" (2 trials), "Lamivudine" (1 trials) and "Lamivudine/Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Body Positive" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Body Positive". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Body Positive, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Body Positive, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".